NOVA LEAP HEALTH CORP (NLH.CA) Forecast, Price Target & Analyst Ratings

TSX-V:NLHCA66980G1090

Current stock price

0.32 CAD
-0.02 (-7.25%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NOVA LEAP HEALTH CORP (NLH.CA).

Forecast Snapshot

Consensus Price Target

Price Target
N/A
N/A

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026

ChartMill Buy Consensus

Rating
84.44%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
N/A
Upside
N/A
From current price of CA$0.32 to mean target of N/A, Based on 9 analyst forecasts
Low
N/A
Median
N/A
High
N/A

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

Analyst Ratings & History

Current Analyst Ratings

NLH Current Analyst RatingNLH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

NLH Historical Analyst RatingsNLH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
84.44%
NLH.CA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NLH.CA.
In the previous month the buy percentage consensus was at a similar level.
NLH.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-11-12Echelon Wealth PartnersReiterate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024
Revenue
YoY % growth
NLH.CA revenue by date.NLH.CA revenue by date.
28.205M
32.55%
26.179M
-7.18%
25.761M
-1.60%
EBITDA
YoY % growth
NLH.CA ebitda by date.NLH.CA ebitda by date.
293.8K
179.43%
1.345M
357.90%
1.447M
7.59%
EBIT
YoY % growth
NLH.CA ebit by date.NLH.CA ebit by date.
-1.062M
13.75%
460.2K
143.33%
863.7K
87.68%
Operating Margin
NLH.CA operating margin by date.NLH.CA operating margin by date.
-3.77%1.76%3.35%
EPS
YoY % growth
NLH.CA eps by date.NLH.CA eps by date.
-0.01
-121.62%
-0.01
-12.50%
N/A
214.44%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NLH.CA Yearly Revenue VS EstimatesNLH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
NLH.CA Yearly EPS VS EstimatesNLH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 0 0.01 0.02 0.03

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

NOVA LEAP HEALTH CORP / NLH.CA Forecast FAQ

When does NOVA LEAP HEALTH CORP (NLH.CA) report earnings?

NOVA LEAP HEALTH CORP (NLH.CA) will report earnings on 2026-05-06.

What is the number of analysts for NLH stock?

The number of analysts covering NOVA LEAP HEALTH CORP (NLH.CA) is 9.